Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.
Saved in:
| Title: | Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study. |
|---|---|
| Authors: | Zeineddine M; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France; School of Pharmacy, Lebanese American University, Byblos, Lebanon., Al-Hajje A; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon., Salameh P; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, 2417, Nicosia, Cyprus., Massouh J; Harley Street Medical Centre, Neurology Institute, Abu Dhabi, United Arab Emirates., Saab G; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon., Al-Roughani R; Amiri Hospital, Kuwait, Kuwait., Ahmed SF; Ibn Sina Hospital, Kuwait, Kuwait., Al-Mahdawi A; Baghdad Medical City Teaching Hospital, Baghdad, Iraq., Shalaby N; Neurology Department, Cairo University, Kasr Alainy School of Medicine, Cairo, Egypt., Inshasi J; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates., Sahraian MA; Multiple Sclerosis Research Center of Tehran University of Medical Sciences, Tehran, Iran., Gouider R; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia., Mrabet S; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia., Al-Khabouri J; Department of Neurology, The Royal Hospital, Muscat, Oman., Shayganneja V; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Chentouf A; Neurology Department, University Hospital Center, Oran, Algeria., Boumediene F; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France., Yamout B; Harley Street Medical Centre, Neurology Institute, Abu Dhabi, United Arab Emirates. Electronic address: yamoutba@gmail.com. |
| Source: | Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Oct; Vol. 90, pp. 105790. Date of Electronic Publication: 2024 Jul 28. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39121598 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zeineddine+M%22">Zeineddine M</searchLink>; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France; School of Pharmacy, Lebanese American University, Byblos, Lebanon.<br /><searchLink fieldCode="AU" term="%22Al-Hajje+A%22">Al-Hajje A</searchLink>; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Salameh+P%22">Salameh P</searchLink>; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, 2417, Nicosia, Cyprus.<br /><searchLink fieldCode="AU" term="%22Massouh+J%22">Massouh J</searchLink>; Harley Street Medical Centre, Neurology Institute, Abu Dhabi, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Saab+G%22">Saab G</searchLink>; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon.<br /><searchLink fieldCode="AU" term="%22Al-Roughani+R%22">Al-Roughani R</searchLink>; Amiri Hospital, Kuwait, Kuwait.<br /><searchLink fieldCode="AU" term="%22Ahmed+SF%22">Ahmed SF</searchLink>; Ibn Sina Hospital, Kuwait, Kuwait.<br /><searchLink fieldCode="AU" term="%22Al-Mahdawi+A%22">Al-Mahdawi A</searchLink>; Baghdad Medical City Teaching Hospital, Baghdad, Iraq.<br /><searchLink fieldCode="AU" term="%22Shalaby+N%22">Shalaby N</searchLink>; Neurology Department, Cairo University, Kasr Alainy School of Medicine, Cairo, Egypt.<br /><searchLink fieldCode="AU" term="%22Inshasi+J%22">Inshasi J</searchLink>; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates.<br /><searchLink fieldCode="AU" term="%22Sahraian+MA%22">Sahraian MA</searchLink>; Multiple Sclerosis Research Center of Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Gouider+R%22">Gouider R</searchLink>; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia.<br /><searchLink fieldCode="AU" term="%22Mrabet+S%22">Mrabet S</searchLink>; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia.<br /><searchLink fieldCode="AU" term="%22Al-Khabouri+J%22">Al-Khabouri J</searchLink>; Department of Neurology, The Royal Hospital, Muscat, Oman.<br /><searchLink fieldCode="AU" term="%22Shayganneja+V%22">Shayganneja V</searchLink>; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.<br /><searchLink fieldCode="AU" term="%22Chentouf+A%22">Chentouf A</searchLink>; Neurology Department, University Hospital Center, Oran, Algeria.<br /><searchLink fieldCode="AU" term="%22Boumediene+F%22">Boumediene F</searchLink>; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Yamout+B%22">Yamout B</searchLink>; Harley Street Medical Centre, Neurology Institute, Abu Dhabi, United Arab Emirates. Electronic address: yamoutba@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101580247%22">Multiple sclerosis and related disorders</searchLink> [Mult Scler Relat Disord] 2024 Oct; Vol. 90, pp. 105790. <i>Date of Electronic Publication: </i>2024 Jul 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2E+V%22">Elsevier B. V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101580247 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-0356 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222110348%22">22110348 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler Relat Disord <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39121598 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.msard.2024.105790 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105790 Titles: – TitleFull: Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zeineddine M – PersonEntity: Name: NameFull: Al-Hajje A – PersonEntity: Name: NameFull: Salameh P – PersonEntity: Name: NameFull: Massouh J – PersonEntity: Name: NameFull: Saab G – PersonEntity: Name: NameFull: Al-Roughani R – PersonEntity: Name: NameFull: Ahmed SF – PersonEntity: Name: NameFull: Al-Mahdawi A – PersonEntity: Name: NameFull: Shalaby N – PersonEntity: Name: NameFull: Inshasi J – PersonEntity: Name: NameFull: Sahraian MA – PersonEntity: Name: NameFull: Gouider R – PersonEntity: Name: NameFull: Mrabet S – PersonEntity: Name: NameFull: Al-Khabouri J – PersonEntity: Name: NameFull: Shayganneja V – PersonEntity: Name: NameFull: Chentouf A – PersonEntity: Name: NameFull: Boumediene F – PersonEntity: Name: NameFull: Yamout B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2211-0356 Numbering: – Type: volume Value: 90 Titles: – TitleFull: Multiple sclerosis and related disorders Type: main |
| ResultId | 1 |